Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
No
API Access
Has API
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
Yes
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
PathAI
Founded
2016
Country
United States
Website
www.pathai.com
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/